Head and Neck Undifferentiated Carcinoma

Head and Neck Undifferentiated Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

67 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 13
Ph III recruiting: 2
Growth YoY: —
Industry share: 8%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07470489	Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer	not yet recruiting	Phase 2	12	M.D. Anderson Cancer CenterOTHER	1	Jul 29, 2026	clinicaltrials
NCT07138261	Taiwanese Anaplastic Thyroid Cancer Registry(TATC)	not yet recruiting	—	100	National Health Research Institutes, TaiwanOTHER	1	Aug 22, 2025